A phase 2, randomized trial of GVAX pancreas and CRS-207 immunotherapy versus GVAX alone in patients with metastatic pancreatic adenocarcinoma: Updated results.
Dung T. Le
No relevant relationships to disclose
Andrea Wang-Gillam
No relevant relationships to disclose
Vincent Picozzi, Jr
No relevant relationships to disclose
Tim F. Greten
No relevant relationships to disclose
Todd S. Crocenzi
No relevant relationships to disclose
Gregory M. Springett
No relevant relationships to disclose
Michael Morse
No relevant relationships to disclose
Herbert Zeh
No relevant relationships to disclose
Deirdre Jill Cohen
No relevant relationships to disclose
Robert Lance Fine
No relevant relationships to disclose
Beth Onners
No relevant relationships to disclose
Jennifer N. Uram
No relevant relationships to disclose
Dan Laheru
No relevant relationships to disclose
Aimee Murphy
Employment or Leadership Position - Aduro Biotech
Stock Ownership - Aduro Biotech
Justin Skoble
Employment or Leadership Position - Aduro Biotech
Stock Ownership - Aduro Biotech
Ed Lemmens
Employment or Leadership Position - Aduro Biotech
Stock Ownership - Aduro Biotech
John J. Grous
Consultant or Advisory Role - Aduro Biotech
Thomas Dubensky
Employment or Leadership Position - Aduro Biotech
Stock Ownership - Aduro Biotech
Dirk G. Brockstedt
Employment or Leadership Position - Aduro Biotech
Stock Ownership - Aduro Biotech
Elizabeth M. Jaffee
No relevant relationships to disclose